Accessibility Accessibility icon
CONSULTATION (303) 951-5829
Accent Image
Breast Augmentation Option Pulled in the UK

Breast Augmentation Option Pulled in the UK

BEAUTY by BUFORD ImageBEAUTY by BUFORD Image

April 27, 2012

 
As the worldwide popularity of breast enhancement continues to grow, so do the seemingly endless options for achieving it.  But, as is often true, many of these so-called options are proving to be too good to be true and less effective than their conventional counterparts.

At present time, the most common procedure used for increasing breast volume is placement of a saline or silicone gel breast implant.  Breast implants can be placed through relatively small incisions either above or below the muscle in a procedure that generally takes no longer than 60-90 minutes and which is associated with very little downtime.  But the biggest advantage is that even though your breasts will potentially change with the aging process, the results overall are very predictable.  Even so, alternate options are being offered which claim to offer advantages over this standard approach.

Over the last few years in the UK, some practitioners have been using a hyaluronic acid based filler known as Macrolane to effectively add volume and enhance cup size.  The main advantage of this procedure was that it could be performed in an office setting with very little downtime and potentially with more finesse with respect to volume control.  But, as with many of these alternatives, it also had its downsides.  First, because it is a filler, there was no guarantee as to duration.  And so that wonderful augmentation today could literally be a thing of the past in as little as 12 months or less depending upon how your body resorbed the product.  But the biggest concern and the reason that this procedure has now been pulled in the UK is that the product may potentially interfere with the ability to adequately perform a screening mammogram.  And because of this concern, the use of Macrolane for breast augmentation is now being discouraged.  To read more about this, please visit the following link: http://www.netdoctor.co.uk/interactive/news/controversial-breast-treatment-to-be-withdrawn-id801346389-t116.html

Patients today are more engaged and more educated about healthcare options and, as a result, are better able to make decisions related to their care.  At BEAUTY by BUFORD, we encourage every one of our clients to be an informed consumer and to actively participate with us in achieving their goals.  If you have questions about Macrolane or breast augmentation in general, we encourage you to either send us an email or call to schedule a consultation.  303.747.6719

We look forward to working with you!

Visualize your NEW LOOK in 3D NOW

START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Natrelle® Breast Implants are for breast augmentation and revision surgery in women at least 22 years old for silicone-filled implants and women at least 18 years old for saline-filled implants.

You should not get breast implants if you currently have an active infection, untreated breast cancer or precancer, or are pregnant or nursing. Tell your doctor about any conditions you have, any medications you are taking, and any planned cancer treatments. Breast implantation is likely not a one-time surgery.

Having implants removed and not replaced may lead to permanent cosmetic changes of the breasts. Breast implants may affect breastfeeding. Gel implants may rupture without symptoms, so periodic imaging after surgery is recommended.

Key complications are reoperation, implant removal, implant rupture, implant deflation with saline-filled implants, and severe capsular contracture.

Talk to your doctor for more information.

The use of Natrelle® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.

Visualize your
NEW LOOK in 3D NOW!

Start now
START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.